Lynavoy Tablet, Film Coated
Product Images NDC 69516-140

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lynavoy (NDC 69516-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Intercept Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lynavoy 01)

Chemical structure of Linerixibat, the active ingredient in Lynavoy 40 mg film-coated tablets. The diagram shows the molecule's atoms and bonds with specific stereochemistry indicated by wedges.*

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Label for Lynavoy (linerixibat) 40 mg film-coated oral tablets, containing 60 tablets per container. The label includes storage instructions, manufacturer information (Intercept Pharmaceuticals Inc), and a barcode. The product is prescription only and made in China. The label also advises not to accept if the safety seal is missing or broken.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.